Janssen Pharmaceuticals and Idenix Pharmaceuticals are working together on clinical development of direct-acting antiviral combination treatments for hepatitis C virus. The collaboration covers a drug-drug interaction study, followed by a midstage trial. The trials will be conducted by Idenix.
Idenix, Janssen work on hepatitis C treatments
SmartBrief Job Listings for Health Care